Table 1.
Clinicopathological data of patients with periprosthetic joint infection.
| SEX | age | op | bacteria for 1st op | PMNs in intraop | PMNs in permanent | culture (second stage) | comorbidity | DM | BMI | WBC | Hb | CRP | follow-up (days) | Relapse |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F | 69 | reTHA | MRCNS | <5 | <5 | – | RA | 22.4 | 4350 | 11.2 | 0.10 | 2917 | ||
| F | 74 | BHA | Unspecified | <5 | <5 | – | – | 22.9 | 4090 | 12.5 | 0.27 | 2400 | ||
| M | 70 | BHA | MRCNS | <5 | <5 | – | – | 22.4 | 4390 | 13.4 | 0.12 | 3005 | ||
| F | 72 | THA | MRSA | <5 | <5 | – | ITP | 23.2 | 3700 | 11.6 | 0.65 | 3304 | ||
| F | 58 | BHA | Unspecified | <5 | <5 | CNS | 19.8 | 4000 | 12.7 | 0.41 | 3636 | |||
| M | 37 | BHA | MRCNS | <5 | <5 | – | 18.2 | 3910 | 13.1 | 0.17 | 952 | |||
| F | 66 | BHA | MRCNS | <5 | <5 | – | MC | + | 17.4 | 2920 | 11 | 0.02 | 937 | |
| M | 68 | THA | MRSA | <5 | <5 | – | 19.3 | 4190 | 11.8 | 0.12 | 958 | |||
| F | 72 | THA | Unspecified | <5 | <5 | CNS | 20.6 | 3460 | 10.3 | 0.12 | 914 | |||
| M | 77 | TKA | Unspecified | <5 | <5 | – | 24.2 | 4640 | 11.8 | 0.23 | 1086 | |||
| F | 72 | TKA | MSSA | <5 | <5 | – | 28.4 | 7020 | 12.6 | 0.14 | 2079 | |||
| F | 66 | TKA | MSSA | <5 | <5 | – | 23.1 | 4160 | 11.3 | 0.24 | 2889 | |||
| F | 74 | THA | Staphylococcus aureus | <5 | <5 | – | + | 26.9 | 4350 | 11.0 | 0.09 | 1093 | ||
| M | 77 | THA | Unspecified | <5 | <5 | – | AF | 27.9 | 3860 | 11.7 | 0.14 | 926 | ||
| F | 83 | TKA | Unspecified | ≥5 | <5 | – | 20.9 | 4230 | 11.2 | 0.67 | 1803 | |||
| M | 78 | TKA | Streptococcus agalactiae | <5 | <5 | – | – | 19.3 | 3900 | 10.9 | 0.23 | 1032 | ||
| M | 65 | reTHA | unspecified | <5 | ≥5 | – | CI | 30.2 | 3670 | 13.6 | 0.11 | 1824 | ||
| F | 57 | THA | unspecified | <5 | ≥5 | – | – | + | 24.4 | 3860 | 12.5 | 0.15 | 1987 | |
| M | 54 | BHA | unspecified | <5 | ≥5 | – | CI | + | 21.0 | 5930 | 13.3 | 0.02 | 1025 | |
| M | 52 | BHA | unspecified | <5 | ≥5 | – | drug addict | 24.9 | 4800 | 10.7 | 0.01 | 884 | ||
| F | 70 | BHA | unspecified | <5 | ≥5 | – | - | + | 21.8 | 5280 | 11.6 | 0.11 | 1063 | |
| F | 66 | THA | unspecified | <5 | ≥5 | – | RA | 14.4 | 4020 | 10.3 | 3.62 | 777 | ||
| F | 78 | TKA | MSSA | ≥5 | ≥5 | – | 24.4 | 3010 | 12.3 | 0.09 | 1406 | |||
| M | 70 | THA | unspecified | <5 | <5 | – | CI | 22.0 | 4790 | 12.9 | 0.05 | 1219 | + | |
| M | 51 | TKA | MRCNS | <5 | <5 | MRSA | 25.8 | 6820 | 12.5 | 0.06 | 2219 | + |
reTHA: revision THA, BHA: bipolar hip arthroplasty, THA: total hip arthroplasty, TKA: total knee arthroplasty, MRCNS: methicillin-resistant coagulase negative staphylococcus, MRSA: methicillin-resistant Staphylococcus aureus, MSSA: methicillin-sensitive Staphylococcus aureus, CNS: coagulase-negative Staphylococcus, PMNs: polymorphonuclear leukocytes, ITP: idiopathic thrombocytopenic purpura, MC: multiple cancer, RA: rheumatoid arthritis, AF: atrial fibrillation, CI: cerebral infarction, DM: diabetes mellitus, BMI: body mass index, Hb: hemoglobin, WBC: white blood cell count/ml, CRP: C-reactive protein (mg/dL).